Mercury Lab Peer Comparison

BSE: 538964

₹810.00

₹-7.00 (-0.86%)

As on 23-Sep-2026IST

Market cap

₹97 Cr

Revenue (TTM)

₹74 Cr

P/E Ratio

23.3

P/B Ratio

1.7

Div. Yield

0.4 %

Edit

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	97	21,217	20,284	17,618	18,377
Revenue (₹ Cr)	74	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	4.16	678.07	273.51	666.92	735.15
Net Margin (%)	5.51	28.10	16.19	20.60	26.88
RoE (%)	7.80	19.73	11.15	18.75	19.16
Price to Earnings	23.35	31.89	68.22	27.36	25.00
Price-To-Book	1.67	5.78	7.55	4.37	4.17

Income Statement (₹ Cr)

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	73.76	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	75.59	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	65.88	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	7.88	796.58	478.55	1,139.61	941.63
Depreciation	3.31	78.10	126.01	281.06	57.58
EBIT	4.58	718.48	352.55	858.55	884.05
Interest	0.52	0.88	52.11	190.64	7.69
Other Income	1.83	125.96	7.37	7.45	165.62
Exceptional Items	-0.40	0.00	12.16	-17.24	-49.16
Profit before Tax	5.48	843.56	319.96	658.12	992.82
Provision for Tax	1.32	165.49	46.45	-8.80	257.67
Profit after Tax	4.16	678.07	273.51	666.92	735.15

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	58.08	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	0.00	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	9.32	28.74	266.35	1,392.75	91.50
Current Liabilities	11.69	385.94	848.06	2,077.10	627.48
Total Liabilities	74.24	3,207.85	3,310.68	6,865.52	4,911.11

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	32.78	1,291.22	2,525.44	5,617.77	770.28
Current Assets	44.95	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	74.24	3,207.85	3,310.68	6,865.52	4,911.11
Total Debt*	4.09	0.55	586.37	2,421.66	2.50
Net Current Assets	33.26	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	3.26	0.64	76.22	51.96	363.79

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	4.00	432.37	132.27	1,065.01	659.75
Cash Flow from Investing Activities	-9.04	-334.73	-199.13	-79.97	-71.34
Cash from Financing Activities	-0.99	-38.32	62.65	-881.32	-205.34
Net Cash Inflow / Outflow	-6.03	59.32	-4.21	103.72	383.07

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	9.14	26.22	6.95	13.59	26.21
ROE (%)	7.80	19.73	11.15	18.75	19.16
ROA (%)	5.43	18.69	7.80	9.26	14.95
EBIT Margin (%)	6.20	31.41	20.95	26.58	34.40
Net Margin (%)	5.51	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	-3.65	15.01	27.91	9.59	10.69
EBIT Growth (%)	-3.54	18.45	58.32	16.84	24.14
Net Profit Growth (%)	10.42	19.61	149.56	62.68	-9.09
EPS Growth (%)	17.74	17.73	-3.57	67.41	14.40
Book Value Growth (%)	5.37	23.77	30.63	10.19	17.30

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	21.90	31.89	72.37	26.67	23.82
Price / Book Value	1.67	5.78	7.55	4.37	4.17
Dividend Yield (%)	0.43	0.29	0.06	0.00	1.87
EV/EBITDA	12.58	25.37	43.67	17.43	16.22
Market Cap (₹ Cr)	98.28	15,219.80	6,484.12	19,292.77	18,318.10

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.12	0.00	0.07	0.24	0.00
Short term debt to equity ratio	0.01	0.00	0.13	0.14	0.00
Current Ratio	3.85	6.70	1.31	0.74	6.06
Quick Ratio	3.24	5.59	0.88	0.53	5.31
Interest Coverage	11.46	959.59	7.14	4.45	130.11

	Mercury Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	35.04	36.10	30.84	21.07	7.07
Asset Turnover	0.96	0.63	0.48	0.45	0.52
Receivable days	115.65	110.70	118.15	54.06	29.10
Inventory Days	32.60	65.86	98.29	32.16	69.53
Payable days	152.93	105.88	128.16	140.91	76.77
Cash Conversion Cycle	-4.69	70.68	88.28	-54.69	21.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.